EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 28 October 2015. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q2 Un-audited): Consolidated EPS was Tk. 3.18 for July-September, 2015 as against Tk. 2.09 for July-September, 2014; Consolidated EPS was Tk. 6.09 for April-September, 2015 as against Tk. 4.32 for April-September, 2014. Consolidated NOCFPS was Tk. 6.87 for April-September, 2015 as against Tk. 3.94 for April-September, 2014. Consolidated NAV per share was Tk. 53.37 as of September 30, 2015 and Tk. 49.86 as of March 31, 2015.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf4d5a6b000040063533
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.